Invetx

About:

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

Website: https://www.invetx.com

Twitter/X: invetx

Top Investors: AbCellera, F-Prime Capital, Google Ventures, Novo Holdings, Casdin Capital

Description:

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for animal health. Invetx's network includes animal and human health experts, veterinary scientists, and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.

Total Funding Amount:

$85.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)invetx.com

Founders:

Juergen Horn

Number of Employees:

11-50

Last Funding Date:

2022-05-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai